130 related articles for article (PubMed ID: 6831687)
1. Development and analytical performance of automated tests for antithrombin III and plasminogen on the Du Pont aca analyzer.
Perry JF; Siefring GE; Reider MC; Coleman PL; Wehrly JA
Clin Chem; 1983 Apr; 29(4):609-13. PubMed ID: 6831687
[TBL] [Abstract][Full Text] [Related]
2. Development and analytical performance of a functional assay for fibrinogen on the Du Pont aca analyzer.
Siefring GE; Riabov DK; Wehrly JA
Clin Chem; 1983 Apr; 29(4):614-7. PubMed ID: 6187499
[TBL] [Abstract][Full Text] [Related]
3. Coagulation testing with the Du Pont aca discrete clinical analyzer.
Pierson-Perry JF; Wehrly JA; Siefring GE
Semin Thromb Hemost; 1983 Oct; 9(4):321-33. PubMed ID: 6658463
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of an automated assay of effective heparin activity in plasma.
Pierson-Perry JF; Obzansky DM; Mizzer JP
Clin Chem; 1987 Sep; 33(9):1630-4. PubMed ID: 3621562
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
Ito RK; Statland BE
Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptide substrates in hemostatic testing.
Fareed J; Messmore HL; Walenga JM; Bermes EW
Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
[TBL] [Abstract][Full Text] [Related]
7. Automation of plasma antithrombin III assays.
Holmes EW; Fareed J; Bermes EW
Clin Chem; 1981 Jun; 27(6):816-8. PubMed ID: 7237757
[TBL] [Abstract][Full Text] [Related]
8. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
Aiach M; Léon M; Michaud A; Capron L
Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
[No Abstract] [Full Text] [Related]
9. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples.
Gram J; Jespersen J
Thromb Haemost; 1985 Apr; 53(2):255-9. PubMed ID: 4024036
[TBL] [Abstract][Full Text] [Related]
10. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
Hortin GL; Tollefsen DM; Santoro SA
Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin III and fibrinogen measurement using the Du Pont aca discrete clinical analyzer--a reply.
Roche PA
Am J Clin Pathol; 1984 Feb; 81(2):276-7. PubMed ID: 6695864
[No Abstract] [Full Text] [Related]
12. Two automated methods for plasma antithrombin III compared, and the clinical significance of the results.
Prellwitz W; Schmitt KF; Machner M; Schuster CJ; Weilemann L
Clin Chem; 1982 Nov; 28(11):2249-53. PubMed ID: 6812990
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
[TBL] [Abstract][Full Text] [Related]
14. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
Preissner KT; Müller-Berghaus G
Eur J Biochem; 1986 May; 156(3):645-50. PubMed ID: 3699029
[TBL] [Abstract][Full Text] [Related]
15. A sensitive colorimetric assay for thrombin, prothrombin and antithrombin III in human plasma using a new synthetic substrate.
Hitomi Y; Kanda T; Niinobe M; Fujii S
Clin Chim Acta; 1982 Mar; 119(3):157-64. PubMed ID: 6461438
[TBL] [Abstract][Full Text] [Related]
16. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
Bas BM; Costongs GM; Janson PC
Haemostasis; 1987; 17(5):260-7. PubMed ID: 3478286
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
18. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
19. Increased concentrations of heparin cofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin III.
Gram J; Jespersen J
Clin Chem; 1989 Jan; 35(1):52-5. PubMed ID: 2910581
[TBL] [Abstract][Full Text] [Related]
20. Applications of high-performance liquid chromatography to the characterization of the interactions of heparin with antithrombin III and thrombin.
Lahiri B; Danishefsky I
Anal Biochem; 1983 Feb; 129(1):46-50. PubMed ID: 6859531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
